Facebook Inc (FB), Splunk Inc (SPLK): Billionaire Noam Gottesman’s 5 Favorite Stock Picks

Page 1 of 2

Noam Gottesman took the knowledge he gleaned from the halls of Lehman Brothers and Goldman Sachs and co-founded his own fund, GLG Partners, in 1995. Since then, the fund’s AUM has reached into the ten-figures, as has Gottesman’s personal wealth. Similar to quarters past, the fund is required by the SEC to release its positions four times a year in a document known as a 13F filing. We take particular interest in these filings, as we’ve found that the most popular small cap stocks amongst hedge fund managers beat the market by 18 percentage points a year on average; learn more about this strategy here. Let’s take a closer look at GLG’s five largest equity positions by market value.

Facebook & Splunk

Facebook Inc (NASDAQ:FB) takes the top spot on our list, with GLG adding 330,000 shares to its position compared to a quarter prior. Loaded with 2.5mm total shares now, the fund’s holdings carry a market value of over $64mm. Facebook Inc (NASDAQ:FB) stock has struggled through this year, posting a 9.5% loss since the start of 2013. The social network has been in talks to purchase Israeli start-up Waze, although the deal may never come to fruition with Waze not willing to relocate to Silicon Valley. Rumors also hold that Google Inc (NASDAQ:GOOG) has come into the bidding picture as well. Billionaire Leon Cooperman of Omega Advisors has about 3.6mm shares of Facebook Inc (NASDAQ:FB) in his portfolio; check out the fund’s positions here.


Splunk Inc (NASDAQ:SPLK) is an innovative software developer in the data collection and organization arena that has grabbed a $61.6mm chunk out of GLG’s AUM. The young $4.7bn company has seen multiple new coverages from the sell-side with bullish tilts; most recently, Pac Crest and FBR have delivered positive comments. This sentiment has helped push the stock up nearly 60% in 2013 alone. Famed tech investor and billionaire Jim Simons of Renaissance Technologies has slightly under 1.1mm shares of Splunk Inc (NASDAQ:SPLK) – compare that to GLG’s 1.5mm.

The best of the rest

Walgreen Company (NYSE:WAG) makes an appearance near the top of GLG’s portfolio with a $58mm investment from the fund, amounting to 1.2mm shares. The retail drug store has had an outstanding 52 weeks in terms of price appreciation; the stock is up over 60% for those who jumped in this time last year. Besides that incredible growth aspect, income investors will like Walgreen Company (NYSE:WAG)’s 2.2% dividend yield, which was recently highlighted as a top dividend pick by Goldman Sachs (although the bank did remove Walgreen from its Conviction Buy list in March). Billionaire Israel Englander of Millennium Management owns roughly 600,000 shares of Walgreen.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!